Hospital

Potassium-Sparing Diuretics

This family of diuretics was invented to avoid the potassium loss common with loop and thiazide diuretics.

Potassium-sparing diuretics include drugs such as amiloride hydrochloride (Midamor), spironolactone (Aldactone), and triamterene (Dyrenium), among others.

Likely Harmful Interaction

Potassium-sparing diuretics cause the kidneys to hold potassium in the body. When you are taking these medications you generally should not take potassium supplements because your potassium levels might rise too high.

Treatments that combine thiazide diuretics (which cause potassium loss) and potassium-sparing diuretics can affect potassium levels unpredictably. If you are taking such a combination medication, do not take potassium except on the advice of your physician.

Possible Harmful Interaction

Preliminary evidence from animal studies suggests that the potassium-sparing diuretic amiloride might cause the body to retain magnesium also, along with potassium.2 Therefore, taking magnesium supplements might conceivably present the risk of excessive magnesium levels.

Possible Harmful Interaction

Based on experience with intravenous arginine, it is possible that the use of high-dose oral arginine might alter potassium levels in the body, especially in people with severe liver disease.1 This is a potential concern for individuals who take potassium-sparing diuretics.

Possible Negative Interaction

The herb white willow contains substances very similar to aspirin. On this basis, it might not be advisable to combine white willow with potassium-sparing diuretics.

Possible Harmful Interaction

The potassium-sparing diuretic amiloride was found to significantly reduce zinc excretion from the body.3 This means that if you take zinc supplements at the same time as amiloride, zinc accumulation could occur. This could lead to toxic side effects.

However, the potassium-sparing diuretic triamterene does not seem to cause this problem.4

References

1. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 2000: 2306-2307.

2. Devane J and Ryan MP. The effects of amiloride and triamterene on urinary magnesium excretion in conscious saline-loaded rats. Br J Pharmacol 1981;72:285-289.

3. Reyes AJ, Olhaberry JV, Leary WP, et al. Urinary zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. S Afr Med J. 1983;64:936-941.

4. Wester PO. Urinary zinc excretion during treatment with different diuretics. Acta Med Scand. 1980;208:209-212.

Last reviewed December 2015 by EBSCO CAM Review Board